Attorneys general from 46 states, the District of Columbia and four U.S. territories sued major drug makers for colluding on generic dermatologic drug prices. The latest lawsuit , filed Wednesday (June 10) in the U.S. District Court for the District of Connecticut, targets 26 large drug manufacturers including Pfizer, Sandoz, Taro, Novartis and Mylan. The case focuses on 80 topical generic drugs that account for billions of dollars in sales each year in the United States. Between 2009-2016 the companies...